Local therapies for the global COVID-19 pandemic
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…
CertaraMay 29, 2020
Applying decision analysis to drug development for COVID-19 & future pandemics
This blog discusses how decision analysis approaches can help drug developers to better decisions under…
CertaraApril 30, 2020
Getting started with in-house development: Storyboarding
Introducing our three-part blog series on getting started with in-house development. In this series, we’re…
CertaraFebruary 21, 2020
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
CertaraFebruary 19, 2020
Getting started with in-house development: How does it work?
Introducing our three-part blog series on getting started with in-house development. In this series, we’re…
CertaraFebruary 10, 2020
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs
This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive…
CertaraJanuary 24, 2020
